A sub-pathway-based approach for identifying drug response principal network

Bioinformatics

Volumn 27, Issue 5, 2011, Pages 649-654

  Chen, Xiujie ^a   Xu, Jiankai ^a   Huang, Bangqing ^a   Li, Jin ^a   Wu, Xin ^a   Ma, Ling ^a   Jia, Xiaodong ^a   Bian, Xiusen ^a   Tan, Fujian ^a   Liu, Lei ^a   Chen, Sheng ^a   Li, Xia ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ARTICLE; COMPARATIVE STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; HUMAN; MALE; METABOLISM; METHODOLOGY; PRINCIPAL COMPONENT ANALYSIS; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; DEXAMETHASONE; GENE EXPRESSION PROFILING; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PROSTATIC NEOPLASMS;

EID: 79951976837     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btq714     Document Type: Article

References (37)

1. Akakura,K. et al. (2003) Possible mechanism of dexamethasone therapy for prostate cancer: suppression of circulating level of interleukin-6. Prostate, 56, 106-109.
2. Assenov,Y. et al. (2008) Computing topological parameters of biological networks. Bioinformatics, 24, 282-284.
3. Alimirah,F. et al. (2006) DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett., 580, 2294-2300.
4. Backes,C. et al. (2007) GeneTrail-advanced gene set enrichment analysis. Nucleic Acids Res., 35, W186-W192.
5. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B, 57, 289-300.
6. Dahlquist,K.D. et al. (2002) GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways. Nat. Genet., 31, 19-20.
7. Damian,D. and Gorfine,M. (2004) Statistical concerns about the GSEA procedure. Nat. Genet., 36, 663; author reply 663.
8. De Bosscher,K. et al. (2003) The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev., 24, 488-522.
9. Du,Z. et al. (2009) G-SESAME: web tools for GO-term-based gene similarity analysis and knowledge discovery. Nucleic Acids Res., 37, W345-W349.
10. Fu,L. and Lee,C.C. (2003) The circadian clock: pacemaker and tumour suppressor. Nat. Rev. Cancer, 3, 350-361.
11. Goleva,E. et al. (2008) Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages. J. Allergy Clin. Immunol., 122, 550-559.e3.
12. Gong,X. et al. (2010) Extracting consistent knowledge from highly inconsistent cancer gene data sources. BMC Bioinformatics, 11, 76.
13. Hakem,R. et al. (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell, 94, 339-352.
14. Huang da,W. et al. (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res., 37, 1-13.
15. Kanehisa,M. and Goto,S. (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 28, 27-30.
16. Khatri,P. et al. (2007) Onto-Tools: new additions and improvements in 2006. Nucleic Acids Res., 35, W206-W211.
17. Koliwad,S.K. et al. (2009) Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoidregulated triglyceride metabolism. J. Biol. Chem., 284, 25593-25601.
18. Lamb,J. (2007) The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer, 7, 54-60.
19. Lin,D.Y. (2006) Evaluating statistical significance in two-stage genomewide association studies. Am. J. Hum. Genet., 78, 505-509.
20. Nguyen,T.T. et al. (2009) Optimal robust two-stage designs for genome-wide association studies. Ann. Hum. Genet., 73, 638-651.
21. Nishimura,K. et al. (2001) Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. J. Natl Cancer Inst., 93, 1739-1746.
22. Rhee,K. et al. (1995) c-Myc and cyclin D3 (CcnD3) genes are independent targets for glucocorticoid inhibition of lymphoid cell proliferation. Cancer Res., 55, 4188-4195.
23. Schwarz-Romond,T. et al. (2002) The ankyrin repeat protein diversin recruits Casein kinase I epsilon to the beta-catenin degradation complex and acts in both canonical Wnt and Wnt/JNK signaling. Genes Dev., 16, 2073-2084.
24. Shang,Y.C. et al. (2009) FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis. Curr. Neurovasc. Res., 6, 223-238.
25. Sherman,B.T. et al. (2007) DAVID Knowledgebase: a gene-centered database integrating heterogeneous gene annotation resources to facilitate high-throughput gene functional analysis. BMC Bioinformatics, 8, 426.
26. Skol,A.D. et al. (2007) Optimal designs for two-stage genome-wide association studies. Genet. Epidemiol., 31, 776-788.
27. Skurk,C. et al. (2004) TheAkt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J. Biol. Chem., 279, 1513-1525.
28. Subramanian,A. et al. (2007) GSEA-P: a desktop application for gene set enrichment analysis. Bioinformatics, 23, 3251-3253.
29. Subramanian,A. et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA, 102, 15545-15550.
30. Tortora,G. et al. (2008) Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications. Nat. Clin. Pract. Oncol., 5, 521-530.
31. Venkitaraman,R. et al. (2008) Efficacy of low-dose dexamethasone in castrationrefractory prostate cancer. BJU Int., 101, 440-443.
32. Wang,H. et al. (2006) Optimal two-stage genotyping designs for genome-wide association scans. Genet. Epidemiol., 30, 356-368.
33. Waterman,W.R. et al. (2006) Glucocorticoid inhibits the human pro-interleukin lbeta gene (ILIB) by decreasing DNA binding of transactivators to the signal-responsive enhancer. Mol. Immunol., 43, 773-782.
34. Yano,A. et al. (2006) Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells. Clin. Cancer Res., 12, 3003-3009.
35. Zeeberg,B.R. et al. (2005) High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID). BMC Bioinformatics, 6, 168.
36. Zhang,M. et al. (2008) Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics, 24, 2057-2063.
37. Zhong,S. et al. (2003) ChipInfo: software for extracting gene annotation and gene ontology information for microarray analysis. Nucleic Acids Res., 31, 3483-3486.